Catalyst Pharmaceutical
CPRX
CPRX
130 hedge funds and large institutions have $236M invested in Catalyst Pharmaceutical in 2019 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 47 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
28% less capital invested
Capital invested by funds: $327M → $236M (-$91.5M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
79% less call options, than puts
Call options by funds: $70K | Put options by funds: $340K
Holders
130
Holding in Top 10
1
Calls
$70K
Puts
$340K
Top Buyers
| 1 | +$19.1M | |
| 2 | +$14.2M | |
| 3 | +$6.56M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$5.88M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.23M |
Top Sellers
| 1 | -$94.9M | |
| 2 | -$6.24M | |
| 3 | -$5.75M | |
| 4 |
AI
Atom Investors
Austin,
Texas
|
-$5.38M |
| 5 |
BC
Broadfin Capital
New York
|
-$4.67M |